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IL-12-Deficient Mice Are Defective in IFNg
Production and Type 1 Cytokine Responses
Jeanne Magram,* Suzanne E. Connaughton,² as a costimulus required for maximum IFNg secretion
by antigen-activated Th1 cells (Murphy et al., 1994).Rajeev R. Warrier,² Daisy M. Carvajal,²
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subunits, called p40 and p35, referring to their molecularDenise A. Faherty,² and Maurice K. Gately²
masses of 40 and 35 kDa, respectively (Kobayashi et*Department of Biotechnology
al., 1989; Stern et al., 1990). The genes encoding the²Department of Inflammation/Autoimmune Diseases
p40 and p35 subunits are unrelated and map to different³Roche Institute of Molecular Biology
human chromosomes (Sieburth et al., 1992). Both sub-§Department of Toxicology and Pathology
units are required for the biological activity of the cyto-Hoffmann-La Roche, Incorporated
kine (Wolf et al., 1991; Gubler et al., 1991); however,340 Kingsland Street
recent experiments have demonstrated that p40 canNutley, New Jersey 07110
be secreted as a homodimer that behaves as an IL-12
antagonist (Gillessen et al., 1995). IL-12 is synthesized
primarily by antigen-presenting cells, including macro-
phages, monocytes, and dendritic cells (D'Andrea et al.,Summary
1992; Macatonia et al., 1995). Expression of the individ-
ual subunit genes is regulated independently (Trinchieri,IL-12 is a cytokine that can exert regulatory effects
1994), and synthesis of IL-12 heterodimer is invariablyon T and NK cells and promote Th1 responses. To
accompanied by production of a large excess of thedelineate further the physiologic role of IL-12 in immu-
p40 subunit (D'Andrea et al., 1992), although the signifi-nity, mice deficient for this cytokine were generated.
cance of this is not yet known. The p35 gene is moreIL-12-deficient mice were impaired but not completely
ubiquitously expressed than the p40 gene in cell lineslacking in the ability to produce IFNg following endo-
(Trinchieri, 1994); and in mice, the p35 gene is expressedtoxin administration and to mount a Th1 response in
in tissues that do not express the p40 gene, such asvivo, as measured by antigen-induced IFNg secretion
brain and liver (Schoenhaut et al., 1992).by immune lymph node cells in vitro. In contrast, secre-
To evaluate further the role of endogenous IL-12 intion of IL-4 was enhanced, while proliferation and se-
mediating immune responses, mice deficient in IL-12cretion of IL-2 and IL-10 werenormal following antigen
production were generated using homologous recombi-stimulation. DTH responses were significantly re-
nation in embryonic stem (ES) cells. A mutation in theduced in IL-12-deficient mice, but no defect in alloge-
p40 gene was targeted, since expression of this geneneic CTL responses was observed. These results indi-
appeared to be restricted to lymphoid tissues (Schoen-
cate that IL-12 plays an essential role in regulating
haut et al., 1992). Also, p35 in the absence of p40 is
IFNg production and in facilitating normal DTH re- poorly secreted; however, the p40 subunit is efficiently
sponses. However, other phenomena associated with secreted even in the absence of the p35 subunit (Wolf
Th1 responses and cell-mediated immunity, i.e., IL-2 et al., 1991; Gubler et al., 1991). Therefore, mutations in
secretion and CTL generation, were not compromised the p40 gene would result in a lack of secreted IL-12
in the absence of IL-12. heterodimer, p40 monomer, and p40 homodimer.
IL-12-deficient mice developed normally, were fully
fertile, and displayed no obvious defects in any organs
upon necropsy. Nevertheless, these mice were deficientIntroduction
in their ability to produce IFNg in response to several
stimuli and to generate normal Th1 responses, as mea-
Interleukin-12 (IL-12) is a heterodimeric cytokine that sured by antigen-induced IFNg secretion. On the other
has a variety of effects on T and natural killer (NK) cells. hand, their ability to produce IL-2 and to mount alloge-
These include its ability to induce interferon-g (IFNg) neic CTL responses was normal. These results demon-
secretion by T and NK cells, to act as a growth factor strate an important role for IL-12 in promoting some,
for activated T and NK cells, to enhance the lytic activity but not all, facets of cell-mediated immunity associated
of NK/lymphokine-activated killer (NK/LAK) cells, and with Th1 responses.
to facilitate specific cytolytic T lymphocyte (CTL) re-
sponses (reviewed by Trinchieri, 1994; Hendrzak and Results
Brunda, 1995). Furthermore, and possibly most impor-
tantly, IL-12 plays a unique role in regulating the balance Construction of IL-12-Deficient Mice
between the type 1 and type 2 subsets of T helper (Th) To introduce a null mutation into the IL-12 p40 gene, a
cells. Type 1 Th (Th1) cells produce IFNg and IL-2 and replacement targeting vector was created as illustrated
promote primarily cellular immunity, whereas Th2 cells in Figure 1A. Upon homologous recombination, a portion
produce IL-4, IL-5, IL-10, and IL-13 and promote princi- of exon 3 (the second coding exon) was replaced with
pally humoral immunity (Mosmann and Coffman, 1989; a neo cassette. The targeting vector was introduced
Scott, 1993). IL-12 facilitates Th1 responses by stimulat- into W9.5 ES cells (Szabo and Mann, 1994), and G418-
ing the differentiation of naive Th cells into Th1 cells resistant FIAU-resistant colonies were isolated. South-
ern blot analysis was used to distinguish wild-type and(Manetti et al., 1993; Hsieh et al., 1993) and by serving
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Figure 1. Disruption of the IL-12 p40 Gene
(A) IL-12 p40 targeting strategy. IL-12 p40 genomic structure is represented; closed boxes indicate coding exons, open box indicates a
noncoding exon. The MC1±tk gene is indicated by the shaded box; the PGK±neo gene is indicated by the stippled box. BamHI (Bam) and
BglII (Bgl) restriction endonuclease sites are indicated. The probe used for screening by genomic Southern blot analysis is indicated by the
closed bar. The size and location of fragments predicted for wild-type and mutant alleles detected by this screen are indicated by double-
headed arrows.
(B) Identification of IL-12 p402/2 mice. Genomic DNA isolated from tails was digested with BamHI and BglII, electrophoresed, transferred to
membranes and hybridized with the indicated probe as described in the text. 1/1, wild-type; 1/2, heterozygous; 2/2, homozygous IL-12
p40 mutant mice.
mutated IL-12 p40 alleles. Approximately 10% of the by sequencing the product resulting from polymerase
chain reaction using primers in exons 2 (59-GCTAACisolated ES cell colonies contained a correctly targeted
mutation. Two of these clones (J6 and C3) were used CATCTCCTGGTTTGC-39) and 4 (59-CCAGCCATGAG
CACGTGAACC-39; data not shown). This splice wouldto generate chimeric animals by injection into C57BL/
6J blastocysts. Both clones gave rise to highly chimeric result in an mRNA encoding a p40 protein with a deletion
of 89 aa and would therefore be expected to be biologi-mice, which transmitted the mutation through the germ-
line. Heterozygotes from each clone were intercrossed cally inactive. To confirm that this mutant p40 protein
could not contribute to the formation of biologically ac-and produced mice homozygous for the IL-12 p40 muta-
tion as shown in Figure 1B. Both clones gave compara- tive IL-12 heterodimer, the mutant p40 was coexpressed
with p35 in COS cells, and supernatant fluid was col-ble results and therefore will not be described sepa-
rately. lected and analyzed in an IL-12 bioassay. Even when
expressed at higher levels, this immunoreactive proteinTo confirm that mice homozygous for the targeted
mutation were unable to produce biologically active IL- was unable to mediate biological activity (U. Gubler,
12, IL-12 bioassays were performed. The results are
shown in Table 1. As expected, mice homozygous for the
Table 1. IL-12 p402/2 Mice Fail to Produce BiologicallyIL-12 p40 mutation do not produce biologically active IL-
Active IL-1212. However, using an enzyme-linked immunosorbent
assay (ELISA) that detects p40 monomer and dimer, as IL-12 Bioactivity
Mice (pg/ml)well as IL-12 heterodimer, a small amount of immunore-
active protein (<4% of the wild-type level) could be de- IL-12 p401/1 1060
tected. Using Northern blot analysis and reverse tran- IL-12 p402/2 ,5
scriptase polymerase chain reaction with a largenumber
Thioglycollate-elicited peritoneal exudate cells (PEC) obtained from
of primers spread across the coding sequence, it was IL-12 p402/2 mice and control littermates were stimulated to pro-
determined that this protein was translated from an duce IL-12 by culture in the presence of LPS and IFN-g. Levels of
mRNA that resulted from removal of the mutated exon biologically active IL-12 in the supernates were measured using a
phytohemagglutinin-activated lymphoblast proliferation assay. The3 by a precise splice. This determination was possible
results shown were generated using PEC from 2 IL-12 p402/2 micedue to previous characterization of the genomic struc-
assayed individually and pooled PEC from 2 wild-type mice. Theseture of the IL-12 p40 gene (Chizzonite et al., 1996, Mur-
data are representative of three separate experiments.
phy et al., 1995), and this conclusion was confirmed
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maturation or seeding of mature T cells to peripheral
lymphoid tissues.
NK Cell Function in IL-12-Deficient Mice
IL-12 was initially identified on the basis of its ability to
enhance the lytic activity of NK cells (Kobayashi et al.,
1989) and LAK cells (Stern et al., 1990). It was, therefore,
of interest to determine whether IL-12 p402/2 mice dis-
played normal NK lytic activity. In five separate assays
involving a total of 18 wild-type C57BL/6 mice and 20
C57BL/6 IL-12 p402/2 mice, the mean NK lytic activity
of IL-12 p402/2 splenocytes was about 66% of the mean
NK lytic activity of wild-type splenocytes (IL-12 p402/2,
0.84 6 0.14 lytic U/106 splenocytes; wild-type, 1.27 6
0.17 lytic U/106 splenocytes; p < 0.05 by Mann-Whitney
test). However, when splenocytes from wild-type or IL-
12 p402/2 mice were cultured with IL-2 (5, 50, or 500
U/ml) for 3 days, the IL-2-activated NK cell lytic activities
of wild-type and IL-12 p402/2 splenocytes were essen-
tially identical at all concentrations of IL-2 used (data
Figure 2. Flow Cytometric Analysis of Lymphocyte Subset Distribu- not shown).
tions in IL-12 p402/2 and Wild-Type Mice
It was previously reported that treatment of mice with
Cells from indicated tissues were obtained from 6- to 7-week-old neutralizing anti-IL-12 antibodies reduced the produc-
IL-12 p402/2 mice and wild-type littermate controls, stained with tion of IFNg in response to endotoxin lipopolysaccharide
MAbs, and analyzed using flow cytometry. Representative compari-
(LPS) in vivo. Anti-IL-12-treated mice injected with LPSsons of CD4, CD8, TCRa/b, CD3, and B220 markers on thymocytes
displayed serum IFNg levels that were 16%±22% of theand splenocytes are shown. Numbers in each quadrant indicate
levels observed in control LPS-injected mice (Heinzel etthe percent of total cells in that quadrant. The data shown are for
individual mice and are representative of results obtained for 4±5 al., 1994). It was not clear whether the residual IFNg
mice per group from two separate litters. secretion in anti-IL-12-treated mice was due to incom-
plete neutralization of IL-12 or, alternatively, to IFNg
production via an IL-12-independent mechanism. To ex-
amine this, we administered LPS to C57BL/6 wild-typeJ. F. and M. K. G., data not shown). Therefore, these
and IL-12 p402/2 mice and measured serum IFNg levelsmice cannot produce biologically active IL-12.
6 hr later by ELISA. Serum IFNg levels, which were unde-
tectable prior to LPS administration, were substantially
IL-12-Deficient Mice Display Normal Development reduced in IL-12 p402/2 mice as compared with wild-
Mice homozygous for the IL-12 p40 targeted mutation type mice (Figure 3). In four separate experiments using
(IL-12 p402/2 mice) were detected at the expected Men- a total of 22 wild-type and 27 IL-12 p402/2 mice, the
delian frequency (Figure 1B; data not shown). No abnor- LPS-induced IFNg levels in IL-12 p402/2 mice were
malities were detected in organs of heterozygous or 17% 6 5% of the levels seen in wild-type mice. Hence,
homozygous animals upon gross necropsy or histopath- the production of IFNg in response to LPS was largely,
ological examination. Further analysis of hematology but not entirely, IL-12 dependent in this model. Treat-
and clinical chemistry parameters revealed no differ- ment of mice prior to LPS administration with a dose of
ences between wild-type and IL-12 p402/2 mice (data anti-asialo GM1 (ASGM-1) antibody that was previously
not shown). Mice carrying one or two copies of the shown to deplete NK cells selectively in vivo (Gately et
mutated IL-12 p40 allele were also of normal size and al., 1988) reduced LPS-induced IFNg production by >
weight, and both sexes were fully fertile. 85% in both wild-type and IL-12 p402/2 mice (data not
It was previously reported that IL-12 could influence shown). Thus, IFNg produced in response to LPS in
mouse thymocyte proliferation and development in vitro these experiments appeared to be largely NK cell±
(Godfrey et al., 1994). Likewise, both p35 and p40 IL-12 derived.
mRNAs were detected in fetal and adult thymus and
in thymic epithelial cell lines (Schoenhaut et al., 1992; T Cell Function in IL-12-Deficient Mice
Godfrey et al., 1994). Thus, it seemed possible that IL- IL-12 has been shown to play an important role in pro-
12 might influence T cell development in the thymus. moting Th1 responses in a number of mouse models
However, flow cytometric analyses of thymocytes, both in vitro and in vivo (reviewed by Trinchieri, 1994;
splenocytes, and lymph node cells from 6- to 7-week- Hendrzak and Brunda, 1995). Therefore antigen-induced
old C57BL/6 wild-type and IL-12 p402/2 mice revealed cytokine production and T cell proliferation in wild-type
no abnormalities in expression of CD3, CD4, CD8, T and IL-12 p402/2 mice were compared. For this purpose,
cell antigen receptor (TCR) a/b, B220, F4/80, or major mice were immunized with keyhole limpet hemocyanin
histocompatibility complex (MHC) class II antigen in IL- (KLH) in complete Freund's adjuvant (CFA) or with alum-
12 p402/2 mice (Figure 2; data not shown). Hence, IL-12 precipitated KLH combined with heat-killed Corynebac-
terium parvum as adjuvant. Draining lymph nodes weredoes not appear to be required for normal thymocyte
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deficient, but not entirely lacking, in theirability to gener-
ate a type 1 cytokine response, as measured by antigen-
induced IFNg production, and made an enhanced type 2
cytokine response, as monitored by antigen-stimulated
secretion of IL-4.
In addition to IFNg, IL-2 is considered to be a type 1
cytokine (Scott, 1993; Paul and Seder, 1994). Although
IL-10 has been considered a type 2 cytokine (Scott,
1993; Paul and Seder, 1994), administration of rIL-12 to
normal mice was shown to induce the production of IL-
10 (Morris et al., 1994). Likewise, as a result of in vitro
priming of human peripheral blood mononuclear cells
in the presence of IL-12, secretion of IL-10, as well as
IFNg, was enhanced following secondary stimulation
(Chehimi et al., 1996). We therefore compared the abili-
ties of KLH-immune LNC from wild-type and IL-12
p402/2 mice to produce IL-2 and IL-10 in response to
KLH. For mice immunized with KLH in CFA, the ratio of
cytokine produced by IL-12 p402/2 KLH-stimulated LNC
compared with wild-type KLH-stimulated LNC was 1.5
6 0.1 for both IL-2 and IL-10 (Figure 4). Hence, endoge-
nously produced IL-12 appears to play little role in the
regulation of IL-2 or IL-10 production, in contrast with
the dramatic effects it exerts on IFNg production.
In vitro studies have suggested that IFNg acts as a
costimulus with IL-12 in promoting Th1 responses (Se-
der et al., 1993; Schmitt et al., 1994). To evaluate the role
Figure 3. LPS-Induced IFNg Production In Vivo in IL-12 p402/2 and
of IFNg in promoting Th1 responses in KLH-immunizedWild-Type Mice
wild-type and IL-12 p402/2 mice in vivo, mice were
IL-12 p402/2 mice and wild-type C57BL/6J controls were injected treated with neutralizing rat anti-mouse IFNg mono-
with LPS intraperitoneally and bled six hours later. Serum levels of
clonal antibody (MAb) or with recombinant mouse IFNg.IFNg were measured using an ELISA. IFNg levels were undetectable
In vivo treatment with anti-IFNg MAb dramatically re-(< 0.15 ng/ml) prior to administration of LPS. The numbers given
duced IFNg production by KLH-immune wild-type andrepresent averages of 4 wild-type and 6 IL-12 p402/2 mice. Similar
results were obtained in three additional experiments with compara- IL-12 p402/2 LNC, whereas IL-4 production was en-
ble numbers of mice. hanced (Figure 5). Thus, IFNg was essential for the resid-
ual IL-12-independent type 1 cytokine response in IL-
12 p402/2 mice, as well as for normal type 1 cytokine
harvested 4±7 days later; and proliferation and cytokine responses in wild-type mice. To determine whether NK
production by lymph node cells (LNC) cultured with KLH cells, as a possible source of IFNg, played a role in
were examined. LNC from KLH-immune IL-12 p402/2 promoting the type 1 cytokine responses observed in
mice showed a marked deficiency in their ability to se- these studies, wild-type and IL-12 p402/2 mice were
crete IFNg when cultured with KLH, whereas antigen- treated with anti-ASGM-1 antibody to deplete NK cells
induced IL-4 production by KLH-immune IL-12 p402/2 in vivo (confirmed by depletion of splenic NK lytic activ-
LNC was enhanced, and antigen-induced LNC prolifera- ity). In three experiments, anti-ASGM-1 treatment of
tion was normal (Figure 4). In 13 experiments in which mice immunized with KLH caused a modest inhibition
wild-type and IL-12 p402/2 mice were immunized with (41% 6 15%) of KLH-induced IFNg production by wild-
KLH in CFA, the ratio of IFNg produced by IL-12 p402/2 type LNC but did not significantly inhibit (5% 6 12%)
KLH-stimulated LNC compared with wild-type KLH- KLH-induced secretion of IFNg by IL-12 p402/2 LNC
stimulated LNC was 0.12 6 0.02 (mean 6 1 standard (data not shown). Thus, NK cells did not appear to con-
error), and the ratio of IL-4 produced was 2.9 6 0.4. tribute to the residual IL-12-independent type 1 cytokine
In five experiments using mice immunized with alum- response in IL-12 p402/2 mice.
precipitated KLH plus C. parvum, the ratios of antigen- Treatment of KLH-immunized wild-type mice with
induced IFNg and IL-4 production for IL-12 p402/2 LNC recombinant mouse IFNg caused a dose-dependent
compared with wild-type LNC were 0.024 6 0.003 and enhancement of the type 1 cytokine response, as moni-
5.2 6 0.7, respectively. Three experiments in which LNC tored by IFNg secretion; whereas the ability of KLH-
were depleted of CD41, CD81, or asialo GM11 cells by immune IL-12 p402/2 LNC to produce IFNg in response
treatment with the corresponding antibody plus comple- to KLH was only modestly increased (Figure 6A). Treat-
ment prior to culture with KLH indicated that 73%±93% ment of IL-12 p402/2 mice with as much as 20 mg/day
of the IFNg produced by wild-type LNC, >90% of the rIFNg failed to reconstitute IFNg production by KLH-
IFNg produced by IL-12 p402/2 LNC, and >90% of the immune IL-12 p402/2 LNC to the level seen for KLH-
IL-4 produced by both wild-type and IL-12 p402/2 LNC immune LNC from vehicle-treated wild-type mice (Fig-
were derived from CD41 T cells (data not shown). Thus, ure 6A), whereas treatment of IL-12 p402/2 mice with
only 10 ng/day of rIL-12 restored the type 1 cytokinethese experiments indicated that IL-12 p402/2 mice were
IL-12-Deficient Mice
475
Figure 4. Comparison of Antigen-Induced
Cytokine Production and Proliferation by Im-
mune LNC from IL-12 p402/2 and Wild-Type
Mice
IL-12 p402/2 mice on the C57BL/6 genetic
background and wild-type C57BL/6 controls
were immunized with KLH in CFA, and lymph
nodes were harvested 4 days later. LNC were
cultured in the presence of 100 mg/ml KLH
andanalyzed for their ability to proliferate and
produce IFNg, IL-4, IL-2, and IL-10. The val-
ues indicated for IFNg, IL-4, IL-2, IL-10, and
proliferation are the mean and standard error
from multiple independent experiments. Al-
though IFNg and IL-4 were measured in each
of the 10 experiments, IL-2 , IL-10, and prolif-
eration were only measured in six, three, and
four experiments, respectively. LNC cultured
in the absence of KLH did not secrete mea-
surable amounts of any of the 4 cytokines,
andspontaneous [3H]thymidine incorporation
in the absence of KLH was 7480 6 520 cpm
and 7960 6 580 cpm for wild-type and IL-12
p402/2 mice, respectively. Experiments using
IL-12 p402/2 mice on the BALB/c genetic
background and wild-type BALB/c controls
gave comparable results (data not shown).
response to KLH to normal levels (Figure 7A). Thus, CTL responses, IL-12 p402/2 mice were deficient in the
generation of DTH reactions. Wild-type and IL-12 p402/2although the residual IL-12-independent type 1 cytokine
response in IL-12 p402/2 mice was largely IFNg depen- mice were immunized with methylated bovine serum
albumin (MBSA), and DTH reactions were elicited bydent, it could not be reconstituted to normal levels by
administration of large amounts of rIFNg, emphasizing injection of MBSA into the footpads 7 days later. In
four separate experiments, the specific footpad swellingthe essential role of IL-12 in facilitating an optimal type 1
cytokine response. Furthermore, administration of rIFNg reaction at 48 hr after challenge was inhibited by 47% 6
3% in IL-12 p402/2 as compared with wild-type mice.diminished and administration of rIL-12 abolished mea-
surable IL-4 secretion (see Figure 6B; data not shown). Similar inhibition was observed when footpad swelling
was measured at 24 or 72 hr (Figure 8). Histologic exami-Differential regulation of IFNg and IL-2 production was
also evident in these experiments in which wild-type nation of the DTH reaction sites in wild-type and IL-12
p402/2 mice revealed a qualitatively similar histologicalmice immunized with KLH were treated with rIFNg or
rIL-12. Whereas rIFNg and rIL-12 both caused a dose- profile characterized by edema and a cellular infiltrate
composed predominantly of neutrophils, but in the IL-dependent increase in the levels of KLH-induced IFNg
secretion, a dose-dependent decrease in IL-2 levels was 12 p402/2 mice a reduction in the severity of edema,
cellular infiltrate, and myonecrosis was observed (dataobserved (see Figure 6C; Figure 7B).
The production of type 1 cytokines has been shown to not shown).
promote predominantly cell-mediated immunity (Scott,
1993; Paul and Seder, 1994). We thus examined the Discussion
ability of IL-12 p402/2 mice to mount two types of cell-
mediated immune responses: CTL responses and This paper describes the generation and characteriza-
tion of IL-12-deficient mice. These mice were viable,delayed-type hypersensitivity (DTH) reactions. CTL re-
sponses were elicited by immunizing mice with alloge- fertile, of normal size and weight, and had no gross
abnormalities, indicating that IL-12 is not required forneic splenocytes in the footpad and measuring the lytic
activity of cells harvested from draining lymph nodes normal mouse development. This result is consistent
with the hypothesis that IL-12 acts specifically on cells4 days later. For immunization of IL-12 p402/2 mice,
allogeneic IL-12 p402/2 splenocytes were used to pre- of the immune system. Previous in vitro studies had
suggested a possible role for IL-12 in thymopoiesisvent possible IL-12 production by the cells used as im-
munogen. In three separate experiments, IL-12 p402/2 (Godfrey et al., 1994). However, flow cytometry experi-
ments measuring macrophage, T, and B cell markersmice were found to make normal CTL responses. The
ratio of the lytic activity generated in IL-12 p402/2 mice revealed no significant differences between IL-12 p402/2
and wild-type control mice. These results suggest thatto that observed for wild-type mice was 1.4 6 0.1
(mean 6 1 standard error of three experiments; data IL-12 is not required for normal ontogeny of the immune
system. Prior in vitro studies also demonstrated the abil-not shown). As was previously reported in experiments
using wild-type mice (Gatelyet al., 1994), the lytic activity ity of IL-12 to synergize with kit ligand, IL-3, and other
hematopoietic growth factors to support the prolifera-of LNC from alloimmune wild-type and IL-12p402/2 mice
was mediated by antigen-specific CD81 CTL (data not tion and differentiation of hematopoietic progenitor cells
(Jacobsen et al., 1993; Bellone and Trinchieri, 1994).shown). In contrast with their ability to make normal
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Figure 5. Effects of In Vivo Administration of Neutralizing Anti-IFNg
MAb on Cytokine Production by Antigen-Stimulated Immune LNC
In Vitro
IL-12 p402/2 mice on the C57BL/6 genetic background and wild-
type C57BL/6 controls (5 mice per treatment group) were injected
with 1 mg of a neutralizing anti-IFNg MAb or an IgG isotype control
Figure 6. Effects of In Vivo Administration of rIFNg on Cytokineantibody intraperitoneally 1 day prior to immunization. Lymph nodes
Production by Antigen-Stimulated Immune LNC In Vitrowere harvested 4 days after immunization, and LNC were cultured
in the presence of 100 mg/ml KLH followed by analysis of (A) IFNg IL-12 p402/2 mice on the BALB/c genetic background and wild-type
and (B) IL-4 levels. The mean and standard error are shown. The BALB/c controls (5 mice per treatment group) were given 2 or 20
results seen in this experiment were representative of three separate mg of rIFNg or a comparable volume of vehicle intraperitoneally daily
experiments. for 4 days starting on the day of immunization with KLH. Lymph
nodes were harvested 4 days after immunization, and LNC were
cultured in the presence of 100 mg/ml KLH followed by analysis of
(A) IFNg, (B) IL-4, and (C) IL-2 levels. The mean and standard errorNevertheless, no hematologic abnormalities were ob-
for IFNg and IL-4 are shown; IL-2 data were obtained from pooledserved in IL-12 p40 2/2 mice, suggesting that IL-12 is
supernatants. Similar results were obtained in a second experimentnot required for normal hematopoiesis.
using IL-12 p402/2 mice on the C57BL/6 genetic background and
In an assay of NK cell lytic activity, splenocytes from wild-type C57BL/6 controls (data not shown).
IL-12 p402/2 mice displayed approximately 66% the ac-
tivity of splenocytes from wild-type mice. This difference
was statistically significant, but it seems unlikely to be in wild-type mice. In this model, IFNg appeared to be
secreted primarily by CD41 T cells, and the inductionof biological significance. Furthermore, when NK cell
activity was measured following in vitro incubation of of IFNg secretion was specific, since little or no IFNg
was produced when LNC from mice immunized withsplenocytes with IL-2, no difference was observed be-
tween splenocytes from IL-12 p402/2 and wild-type CFA alone were cultured with KLH (M. K. G. and S. E.
C., unpublished data). Additionally, splenocytes from IL-mice. It is of interest to note that similar results were
seen in IFNg-deficient mice (Dalton et al., 1993). 12 p402/2 mice were found to be deficient in their ability
to produce IFNg in vitro in response to LPS or heat-The primary defects observed in IL-12 p402/2 mice
relate to the production of IFNg. Following LPS adminis- killed Listeria monocytogenes (R. R. W. and M. K. G.,
unpublished data).tration, serum IFNg levels in IL-12 p402/2 mice were, on
the average, 17% of the levels seen in wild-type mice. In the model of KLH-induced Th1 responses, further
studies were undertaken to evaluate the factors contrib-In this model, IFNg was produced predominantly by NK
cells. Similarly, Th1 responses as measured by antigen uting to IFNg production in the absence of IL-12. Deple-
tion of IFNg by administration of neutralizing anti-IFNg(KLH)-induced secretion of IFNg by immune LNC from
IL-12 p402/2 mice were <15%of the responses observed MAb in vivo ablated antigen-induced IFNg production
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the differentiation of naive Th cells into Th1 cells (Hsieh
et al., 1993) and serve as a costimulus required for maxi-
mum antigen-induced IFNg secretion by already differ-
entiated Th1 cells (Murphy et al., 1994). Thus, in our
model of Th1 responses to KLH, IL-12 may have been
required for the differentiation of Th1 cells in vivo follow-
ing immunization, for antigen-induced IFNg secretion
in vitro, or for both. Treatment of wild-type mice with
neutralizing anti-IL-12 antibodies in vivo during immuni-
zation or addition of anti-IL-12 to LNC cultures both
led to reduced secretion of IFNg. Maximum inhibition,
resulting in levels of IFNg secretion similar to those seen
in IL-12 p402/2 mice, required antibody treatment both
in vivo and in vitro (M. K. G. and H. Yang, unpublished
data). These results indicate a requirement for IL-12 in
our model both during the differentiation of Th1 cells in
vivo and duringantigen-induced IFNg production by Th1
cells in vitro.
In contrast with the defect in IFNg production, KLH-
immune LNC from IL-12 p402/2mice displayed a moder-
ately enhanced ability to produce IL-4. LNC from IL-12
p402/2mice immunized with KLH in CFA, or with KLH
plus C. parvum, displayed levels of KLH-induced IL-4
secretion 3- or 5-fold greater, respectively, than wild-
type controls. Antigen-induced proliferation of KLH-im-
mune IL-12 p402/2 LNC was normal. This result was
Figure 7. Effects of In Vivo Administration of rIL-12 on Cytokine confirmed in studies using purified KLH-immune CD41
Production by Antigen-Stimulated Immune LNC In Vitro T cellscultured with KLH and irradiated, syngeneic, non-
immune splenocytes as a source of antigen-presentingIL-12 p402/2 mice on the C57BL/6 genetic background and wild-
type C57BL/6 controls (4 mice per treatment group) were injected cells (M. K. G., S. E. C., and R. R. W., unpublished data).
with 10 or 100 ng of rIL-12 or a comparable volume of vehicle Previous experiments using mouse Th1 clones in vitro
intraperitoneally daily for 4 days starting on the day of immunization demonstrated an inhibitory effect of neutralizing anti-
with KLH. Lymph nodes were harvested 4 days after immunization,
IL-12 antibodies on antigen-induced proliferation, asand LNC were cultured in the presence of 100 mg/ml KLH followed
well as IFNg secretion (Murphy et al., 1994; Kennedy etby analysis of (A) IFNg and (B) IL-2 levels. The mean and standard
al., 1994). This apparent discrepancy with our resultserror are shown. The results observed in this experiment were repre-
sentative of three separate experiments. may be due to differences in the state of differentiation
between Th1 clones and the Th cells studied in our
experiments. Specifically, Th1 clones may represent
by immune IL-12 p402/2 LNC and substantially reduced more differentiated cells, which are more dependent
IFNg production by wild-type LNC. In contrast, large upon the presence of IL-12 for maximum proliferation
doses of rIFNg (20 mg/day) were not able to reconstitute than Th1 cells examined 4 days after primary immuni-
IFNg production by IL-12 p402/2 LNC to wild-type levels. zation.
These results are consistent with recent observations Using IFNg secretion as a measure of Th1 responses,
suggesting that the primary role of IFNg in promoting IL-12 p402/2 mice appear to have a severe defect in their
Th1 responses in vivo is to serve as a costimulus re- ability to generate such responses. However, IL-2 is also
quired for optimal IL-12 production by antigen-pres- considered to be a type 1 cytokine (Scott, 1993; Paul
enting cells (Dighe et al., 1995). Administration of as little and Seder, 1994), and yet its secretion is not diminished
as 10 ng/day rIL-12 was able to restore the Th1 response by IL-12 deficiency. Similarly, using an in vitro model, it
to KLH in IL-12 p402/2mice to wild-type levels. In the was reported that IL-12 was required to prime cells for
absence of IL-12, a number of potential inducers could efficient IFNg secretion but did not affect the secretion
contribute to the mechanism by which low levels of IFNg of IL-2 (Hsieh et al., 1993). Our observations that treat-
are produced, including a recently discovered cytokine ment of wild-type mice with rIFNg or rIL-12 both led
called IFNg-inducing factor (Okamura et al., 1995) and to dose-dependent increases in IFNg secretion but no
IFNa (Manetti et al., 1995). Varying production of such increase in IL-2 production provide further evidence that
factors in response to different immunization regimens IL-2 and IFNg secretion are regulated independently.
may account for differences in the level of IL-12-inde- These results are consistent with recent data from other
pendent IFNg production observed. For example, for laboratories, suggesting that production of individual
mice immunized with KLH together with C. parvum as cytokines within the group considered to be products
adjuvant, IFNg production by IL-12 p402/2 LNC was in- of Th1 cells or within the Th2-derived group are indepen-
hibited by 98% compared with wild-type controls; dently regulated (Kelso, 1995; Bucy et al., 1995). This
whereas for mice immunized with KLH in CFA, IFNg further demonstrates a need for analyses based on the
production was inhibited by only 88%. production of different cytokines, rather than using a
single cytokine as an indicator for a particular Th subset.It was previously reported that IL-12can bothpromote
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Figure 8. Measurement of a DTH Response
in IL-12 p402/2 and Wild-Type Mice
We immunized 5 IL-12 p402/2 mice on the
C57BL/6 genetic background and 5 wild-type
C57BL/6 controls with MBSA. The mice were
challenged by injection of MBSA orsaline into
the rear footpads 7 days later, and footpad
swelling was measured at 24, 48, and 72 hr
after challenge. Data are given as specific
swelling calculated by subtracting the
amount of swelling of control saline-injected
footpads from the amount of swelling of
MBSA-injected footpads. The mean and
standard error are shown. Three additional
experiments yielded similar results.
In experiments in which wild-type or IL-12 p402/2 mice administering high doses of rIL-12 to mice but is not a
physiologic effect of endogenous IL-12. The observationwere immunized with KLH and then treated with rIL-12,
a dose-dependent reduction in the levels of IL-2 was that IL-12 p402/2 mice make normal allogeneic CTL re-
sponses also contrasts with a prior report that anti-IL-observed in cultures of IL-12 treated KLH-stimulated
immune LNC (Figure 7B). The reduction in IL-2 levels 12 antibody partially inhibited human allogeneic CTL
responses in vitro (Chouaib et al., 1994). This differenceobserved in these experiments could have been due to
decreased production of IL-2, to increased consumption could reflect either a species difference or a difference in
the requirements for CTL responses in vivo as comparedof IL-2 by the activated LNC, or to both. To evaluate
these possibilities, additional experiments were per- with in vitro. We have also observed partial inhibition of
allogeneic human CTL responses by neutralizing anti-formed in which immune LNC from mice treated with
100 ng/day rIL-12 or with vehicle were incubated with IL-12 antibodies in vitro (M. K. G. and A. Wolitzky, un-
published data), but we have not been able to inhibitKLH in the presence of saturating amounts of a neutraliz-
ing rat anti-mouse IL-2Ra MAb or control rat immuno- allogeneic murine CTL responses in vitro using either
anti-IL-12 antibodies or mouse p40 homodimer (M. K. G.globulin G (IgG). In three experiments using wild-type
mice and one using IL-12 p402/2 mice, the levels of IL-2 and S. E. C., unpublished data). In contrast with their
ability to make normalCTL responses, IL-12 p402/2 miceobserved in cultures of LNC from rIL-12-treated mice
were 8% 6 2% of the levels seen using LNC from vehi- were deficient in the ability to generate DTH responses,
as compared with wild-type mice. This result is consis-cle-treated mice if the cultures contained control IgG,
but 47% 6 8% if anti-IL-2Ra was included in thecultures tent with a report that treatment of mice with neutralizing
anti-IL-12 antiserum suppressed the induction of con-(S. E. C., D. M. C., and M. K. G., unpublished data).
These results suggest that the reduction in IL-2 levels tact sensitivity in mice (MuÈ ller et al., 1995). Taken to-
gether, these results indicate that endogenous IL-12observed in cultures containing LNC from rIL-12-treated
mice was due, at least in part, to increased consumption plays a role in promoting some, but not all, types of cell-
mediated immune responses.of IL-2 by the activated LNC. This increased consump-
tion of IL-2 might reflect rIL-12-induced up-regulation Further studies using IL-12 p402/2 mice to evaluate
the role of endogenous IL-12 in resistance to variousof IL-2R expression, as was previously observed in vitro
(Yanagida et al., 1994). infectious diseases and in the pathogenesis of autoim-
mune diseases are in progress. These studies have im-Th1 cells promote cell-mediated immunity (Scott,
1993; Paul and Seder, 1994). Therefore, we evaluated portant clinical implications for the proposed use of
rIL-12 or IL-12 antagonists in the treatment of such dis-cell-mediated immune responses in IL-12 p402/2 mice
compared with wild-type controls. Although treatment orders.
of mice with exogenous rIL-12 was previously shown
to enhance CTL responses (Gately et al., 1994), IL-12 Experimental Procedures
p402/2mice were capable of making normal CTL re-
sponses, indicating that endogenous IL-12 is not re- Reagents
C57BL/6J and BALB/cByJ mice were from Jackson Laboratory; 129/quired for this response. This apparent discrepancy may
Sv mice were from Taconic. YAC-1 lymphoma cells, EL4 lymphomabe explained by the observation that doses of rIL-12
cells, and P815 mastocytoma cells were maintained in culture asrequired to enhance CTL responses were $ 100 ng/
previously described (Gately et al., 1988).day, at least 10-fold greater than the dose of rIL-12 that
Complete culture medium (CCM) used in these experiments con-
reconstituted a normal Th1 response in IL-12 p40 2/2 sisted of RPMI 1640 (Whittaker Bioproducts) supplemented with
mice. Hence, enhancement of CTL responses appears 100 U/ml of penicillin, 100 mg/ml streptomycin, 2 mM l-glutamine,
0.1 mM nonessential amino acids, 1 mM sodium pyruvate, 0.05to be a pharmacologic effect that can be achieved when
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mM 2-mercaptoethanol (all from GIBCO BRL), and the indicated strain from which W9.5 was derived). 129/Sv progeny carrying the
mutant allele were intercrossed in order to generate mice homozy-percentage of heat-inactivated fetal bovine serum (FBS) (Hyclone).
Purified mouse rIL-12 was prepared as previously described (Gately gous for the mutation. C57BL/6J and BALB/cByJ progeny were
backcrossed to the appropriate parental strain for a total of fiveet al., 1994). Goat anti-mouse IL-12 IgG (Tripp et al., 1994) was from
Dr. J. Hakimi, Hoffmann-La Roche, Incorporated. Purified recombi- backcrosses, andthen intercrossed in order to generate mice homo-
zygous for the mutation on specific genetic backgrounds.nant human IL-2 was supplied by Dr. F. Khan, Hoffmann-La Roche,
Incorporated. MAbs AN-18 and XMG-1.2 to mouse IFNg and purified
recombinant mouse IFNg were provided by Dr. G. Alber, F. Hoff- In Vitro Generation and Assay of IL-12
mann-La Roche, Limited (Basel, Switzerland). Mouse IL-4 and IL-10 To stimulate IL-12 production, thioglycollate-elicited mouse perito-
were from Pepro Tech, Incorporated, and Pharmingen, respectively. neal exudate cells were cultured with 10 mg/ml LPS plus 200
Rabbit anti-ASGM-1 antibody was from Wako Industries, andnormal U/ml mouse rIFNg as previously described (Wilkinson et al., 1996).
rabbit IgG, normal goat IgG, and Salmonella enteritidis LPS were Bioactive IL-12 in the culture supernates was measured in a human
from Sigma Chemical Company. phytohemagglutinin-activated lymphoblast proliferation assay as
described (Gately et al., 1995). The specificity of the proliferative
response was determined by comparing proliferation in culturesConstruction of the Targeting Vector
containing 10 mg/ml goat anti-mouse IL-12 IgG to proliferation inMouse IL-12 p40 genomic clones were isolated from a l library
cultures containing 10 mg/ml normal goat IgG. The amount of IL-12derived from 129/Sv DNA (Stratagene). The inserts were digested
p40 in the supernates was measured by an ELISA as describedwith NotI and EcoRI and the resulting pieces subcloned into pBlue-
previously (Gillessen et al., 1995), except that immunoplates werescript KS(1) (Stratagene). Restriction mapping and further analysis
coated with 4 mg/ml affinity-purified goat anti-mouse IL-12 IgG.were completed using standard techniques (Sambrook et al., 1989).
The targeting vector was generated using four pieces of DNA: up-
stream and downstream flanking DNA, the PGK-1 neo gene (Soriano Lymphoid Cell Phenotype Analysis
Flow cytometric analysis of lymphoid cell phenotypes was per-et al., 1991), and the pMC1±tk gene (Labow et al., 1994). An 8 kb
EcoRI±EcoRI fragment containing exons 2 and 3 from the IL-12 p40 formed as previously described (Gately et al., 1994). MAbs used for
staining thymocytes were anti-TCR (ab)±fluorescein isothiocyanategene was further subcloned into pSP72 (Promega). This plasmid
was then digested with BstXI, and the protruding ends were made (FITC), anti-CD8±phycoerythrin (PE), and anti-CD4±biotin (all from
PharMingen) followed by streptavidin±tricolor (Caltag Laboratories).blunt using T4 DNA Polymerase (Boehringer Mannheim) and de-
phosphorylated using calf alkaline phosphatase (Boehringer Mann- Lymph node cells and splenocytes were stained using anti-CD3±
FITC, anti-CD4±PE, anti-CD8±FITC, anti-B220±PE (all from Phar-heim). This results in an approximately 1.6 kb deletion into which
an XhoI±XhoI fragment containing the PGK-1 neo gene was ligated Mingen), and anti-F4/80±FITC (Harlan Bioproducts). Hamster IgG±
FITC, rat IgG±PE, rat IgG±FITC, and rat IgG±biotin (PharMingen)following removal of the protruding ends using T4 DNA polymerase
(Boehringer Mannheim) generating clone 8. In parallel, an XhoI±SalI were used as isotype controls.
fragment containing the pMC1±tk gene was subcloned into pBlue-
script KS(1). The resultant plasmid was digested with HindIII, and Measurement of Resting and IL-2-Activated NK Cell Activity
a HindIII±HindIII fragment containing exon 1 of the IL-12 p40 gene NK cell lytic activity of fresh mouse splenocytes was determined
was cloned into this site in order to generate clone 10. The clone using YAC-1 target cells as previously described (Gately et al., 1994).
8 insert containing the PGK-1 neo gene and portions of the IL-12 For measurement of IL-2-activated NK cell activity, splenocytes
p40 gene was dissected from the vector using digestion with BglII were cultured at 4 3 106 cells per 1 ml culture in the presence of
and cloned into the BamHI site of clone 10, generating the targeting 500, 50, or 5 U/ml human rIL-2 for 4 days at 378C. Control cultures
vector. This construct was linearized using NotI prior to introduction contained splenocytes without IL-2. The cells were then harvested
into ES cells. and tested for NK lytic activity as described above. Lytic assays
were performed in quadruplicate, and the spontaneous 51Cr release
ranged from 14%±18%.Identification of Targeted ES Cell Clone
The W9.5 ES cell line was maintained on irradiated primary embry-
onic feeder cells as previously described (Abbondanzo et al., 1993) Treatment of Cells with Antibody plus Complement
Pooled lymph node cells were washed and resuspended at 50 3in media containing leukemia inhibitory factor and 15% fetal calf
serum (GIBCO BRL). A confluent plate of ES cells was harvested 106 per ml in CCM with 10% FBS. The cells were then incubated
for 45 min on ice with the following antibodies either alone or inand electroporated with 25 mg of linearized targeting vector using
a Gene Pulser (Bio Rad). The cells were then selected in G418 (350 various combinations: 10 mg/ml anti-CD4 (rat IgM MAb from Cam-
bio), 50 mg/ml anti-CD8 (rat IgM MAb clone AD4 from Accuratemg/ml, GIBCO BRL) and 1-(2-deoxy, 2-fluoro-b-d-arabinofurano-
sil-)-5-iodouracil (FIAU; 0.2 mM, Oclassen Pharmaceutical, Incorpo- Chemical and Scientific), or 25 mg/ml anti-ASGM-1 (Wako). After
incubation for 45 min on ice, cells were washed and incubated withrated), and colonies picked after 10 days and expanded.
A Southern blot strategy was used to determine which of the a 1:5 dilution of rabbit complement (Low Tox-M; Accurate Chemical
and Scientific) for 45 min at 378C. The extent of cell subset depletioncolonies contained a correctly targeted event. Extraction of DNA
from ES cells was performed as previously described (Laird et al., was monitored by flow cytometry.
1991). DNA was digested with BamHI and BglII, fractionated by
agarose gel electrophoresis, transferred to nylon membranes by a LPS-Induced IFNg Production In Vivo
Hoeffer electroblot apparatus, and cross-linked using ultraviolet Mice were injected with 200 mg of LPS intraperitoneally. The mice
light or a Stratalinker (Stratagene). Membranes were hybridized for were bled 6 hr later, and serum IFNg levels were measured by
1 hr in Rapid-Hyb buffer (Amersham) at 658C using a random primed ELISA. In some experiments, mice were depleted of NK cells by
probe. The probe was derived from a downstream region of the IL- administration of 0.8 mg of rabbit anti-ASGM-1 intraperitoneally on
12 p40 gene outside the targeted region and was labeled using a the day prior to injection of LPS. Control mice received normal rabbit
Prime-It kit as per the instructions of the manufacturer (Stratagene). IgG (Sigma) 1 day prior to LPS.
ELISAs for IFNg, IL-4, IL-10, and IL-2Generation of Chimeric Animals
Correctly targeted ES cell clones were karyotyped as described ELISAs for measuring mouse IFNg in sera and culture supernates
were performed as previously described (Gately et al., 1994), except(Abbondanzo et al., 1993) and two clones, J6 and C3, which were
shown to have a normal 40XY karyotype, were used to generate that the assays were developed using TMB Peroxidase (Kirkegaard
and Perry), andabsorbance was measured at 450 nm. The sensitivitychimeric mice. Exponentially growing ES cell clones were injected
into host C57BL/6J blastocysts, and the embryos were then trans- of the assay was z0.15 ng/ml. ELISAs for measuring mouse IL-4
and IL-10 were performed in a similar manner. For measurementplanted into the uterine horns of pseudopregnant C57BL/6J 3
CBA/J F1 females. Chimeric males, as judged by agouti coat color, of IL-4, plates were coated with 2 mg/ml of rat anti-mouse IL-4
(PharMingen), and captured IL-4 was detected using biotinylatedwere mated to C57BL/6J, BALB/cByJ, and 129/Sv females (the
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anti-mouse IL-4 (PharMingen) at 100 ng/ml. The sensitivity of this effect of NK cell stimulatory factor/IL-12 on human hematopoiesis.
J. Immunol. 153, 930±937.assay was z15 pg/ml. To measure IL-10, plates were coated with
1 mg/ml of rat anti-mouse IL-10 (PharMingen), and captured IL-10 Bucy, R.P., Karr, L., Huang, G.-Q., Li, J., Carter, D., Honjo, K., Lem-
was detected using biotinylated anti-mouse IL-10 (PharMingen) at ons, J.A., Murphy, K.M., and Weaver, C.T. (1995). Single cell analysis
500 ng/ml. The sensitivity of the IL-10 ELISA was z0.4 ng/ml. Mouse of cytokine gene coexpression during CD41 T-cell phenotype devel-
IL-2 ELISAs were performedwith a kit from Collaborative Biomedical opment. Proc. Natl. Acad. Sci. USA 92, 7565±7569.
Products and had a sensitivity of z0.8 U/ml.
Chehimi, J., Paganin, C., Frank, I., and Trinchieri, G. (1996). Interleu-
kin-12 in the pathogenesis and therapy of HIV disease. Res. Immu-
Induction of Th1 Responses In Vivo nol., in press.
For induction of Th1 responses in vivo, mice were immunized with
Chizzonite, R., Gubler, U., Magram, J., and Stern, A. (1996). Interleu-KLH (Calbiochem), followed by culture of the immune LNC with
kin 12. In Cytokines, A. Mire-Sluis and R. Thorpe, eds. (London:KLH to elicit cytokine production in vitro. Mice were immunized
Academic Press), in press.subcutaneously at the base of the tail with 100 mg of KLH emulsified
in CFA (GIBCO BRL) or with 100 mg alum-precipitated KLH together Chouaib, S., Chehimi, J., Bani, L., Genetet, N., Tursz, T., Gay, F.,
Trinchieri, G., and Mami-Chouaib, F. (1994). Interleukin 12 induceswith 100 mg heat-killed C. parvum (Wellcome Reagents, Limited).
On day 4, the subinguinal, axillary, and para-aortic lymph nodes the differentiation of major histocompatibility complex class
I±primed cytotoxic T-lymphocyte precursors into allospecific cyto-were removed aseptically, passed through a wire mesh, washed,
and cultured in CCM supplemented with 10% FBS and 0, 10, or 100 toxic effectors. Proc. Natl. Acad. Sci. USA 91, 12659±12663.
mg/ml of KLH. For measurement of cytokine production, LNC were Dalton, D.K., Pitts-Meek, S., Keshav, S., Figari, I.S., Bradley, A., and
incubated in 1 ml cultures in Costar 24-well plates at 6 3 106 cells/ Stewart, T.A. (1993). Multiple defects of immune cell function in mice
well. Culture supernates were harvested by centrifugation after 24 with disrupted interferon-g genes. Science 259, 1739±1742.
hr (for IL-2 ELISA) or 48 hr (for IFNg, IL-4, and IL-10 ELISAs) and
D'Andrea, A., Rengaraju, M., Valiante, N.M., Chehimi, J., Kubin, M.,stored at 48C until assayed. In all experiments, cytokine production
Aste, M., Chan, S.H., Kobayashi, M., Young, D., Nickbarg, E., Chiz-by LNC cultured without KLH was assayed; however, since cytokine
zonite, R., Wolf, S.F., and Trinchieri, G. (1992). Production of naturallevels were routinely below the level of detection in such cultures,
killer cell stimulatory factor (interleukin-12) by peripheral blood mo-these results are not shown. For measurement of proliferative re-
nonuclear cells. J. Exp. Med. 176, 1387±1398.sponses, LNC were plated in 96-well flat-bottomed microplates
Dighe, A.S., Campbell, D., Hsieh, C.-S., Clarke, S., Greaves, D.R.,(Costar) at 6 3 106 cells/ml in 200 ml total volume. After incubation
Gordon, S., Murphy, K.M., and Schreiber, R.D. (1995). Tissue-spe-for 3 days at378C, cultures were pulsedwith 0.5mCi/well of [3H]thym-
cific targeting of cytokine unresponsiveness in transgenic mice.idine for 5±6 hr, and incorporation of radiolabel into DNA was mea-
Immunity 3, 657±666.sured by liquid scintillation counting.
Gately, M.K., Anderson, T.D., and Hayes, T.J. (1988). Role of asialo-
GM1-positive lymphoid cells in mediating the toxic effects of recom-In Vivo Generation of CTL
binant IL-2 in mice. J. Immunol. 141, 189±200.CTL responses were induced by footpad injection of 107 allogeneic
splenocytes, and CTL activity in the draining popliteal lymph nodes Gately, M.K., Warrier, R.R., Honasoge, S., Carvajal, D.M., Faherty,
was measured 4 days later, as previously described (Gately et al., D.A., Connaughton, S.E., Anderson, T.D., Sarmiento, U., Hubbard,
1994). LNC populations were assayed for lytic activity at serial 2-fold B.R., and Murphy, M. (1994). Administration of recombinant IL-12
dilutions, starting at an effector:target ratio of 160:1. Lytic assays to normal mice enhances cytolytic lymphocyte activity and induces
were performed in triplicate, and thespontaneous 51Cr release varied production of IFNg in vivo. Int. Immunol. 6, 157±167.
from 9%±16%.
Gately, M.K., Chizzonite, R., and Presky, D.H. (1995). Measurement
of human and mouse interleukin 12. In CurrentProtocols in Immunol-
DTH Reactions ogy, Volume 1, J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M.
Mice were sensitized to MBSA (Sigma) by intradermal injection of Shevach, and W. Strober, eds. (New York: John Wiley and Sons,
50 ml of 5 mg/ml MBSA in CFA at two sites on the abdomen. On Incorporated), pp. 6.16.1±6.16.15.
day 8 following immunization, the mice were challenged by injection
Gillessen, S., Carvajal, D., Ling, P., Podlaski, F.J., Stremlo, D.L.,of 20 ml of 5 mg/ml MBSA into one rear footpad, while the other
Familletti, P.C., Gubler, U., Presky, D.H., Stern, A.S., and Gately,rear footpad received a comparable volume of phosphate-buffered
M.K. (1995). Mouse interleukin-12 (IL-12) p40 homodimer: a potentsaline. Measurements of footpad swelling were taken at 24, 48, and,
IL-12 antagonist. Eur. J. Immunol. 25, 200±206.in some experiments, 72 hr after challenge by use of a micrometer
Godfrey, D.I., Kennedy, J., Gately, M.K., Hakimi, J., Hubbard, B.R.,(Mitutoyo Corporation). Measurements were made by an observer
and Zlotnik, A. (1994). IL-12 influences intrathymic T cell develop-who was unaware of the identity of the mice. The magnitude of
ment. J. Immunol. 152, 2729±2735.the DTH responses was determined from differences in footpad
thickness between the antigen-and diluent-injected footpads. For Gubler, U., Chua, A.O., Schoenhaut, D.S., Dwyer, C.M., McComas,
examination of histology of the DTH reaction sites, feet were fixed W., Motyka, R., Nabavi, N., Wolitzky, A.G., Quinn, P.M., Familletti,
in 10% neutral buffered formalin, embedded in paraffin, sectioned P.C., and Gately, M.K. (1991). Coexpression of two distinct genes
at 6 mm, and stained with hematoxylin and eosin. is required to generate secreted, bioactive cytotoxic lymphocyte
maturation factor. Proc. Natl. Acad. Sci. USA 88, 4143±4147.
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